Tazanolast

This classification denotes a mast cell stabilizer with the molecular formula C13H15N5O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T0248823H1, chemically known as acetic acid, oxo((3-(1h-tetrazol-5-yl)phenyl)amino)-, butyl ester but generally known as tazanolast, which bears US NIH Compound Identifier 5380. European Medicines Agency schedules Tazanolast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10843MIG. The term TAZANOLAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). TAZANOLAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tazanolast under HS 29339990 and SITC 51577. As of Q4 2014, TAZANOLAST remains the US FDA Preferred Term for this commodity. Tazanolast bears US NLM identifiers UMLS ID C0539675 and NCI Concept Code C76764. SMILES: O(CCCC)C(=O)C(=O)NC1CC(CCC1)C1N[NH]NN1.